Ray Dalio's BSX Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 159,729 shares of Boston Scientific Corporation (BSX) worth $15.59 M, representing 0.06% of the portfolio. First purchased in 2013-Q4, this long-term strategic position has been held for 48 quarters.
Based on 13F filings since 2013, Ray Dalio has maintained a long-term strategic position in BSX, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2022, adding 818,484 shares. Largest reduction occurred in Q3 2024, reducing 815,182 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Boston Scientific Corporation (BSX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Boston Scientific Corporation (BSX) Trades by Ray Dalio
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2013 | +123,584 | New Buy | 123,584 | $12.02 |
| Q1 2014 | -86,700 | Reduce 70.15% | 36,884 | $13.53 |
| Q2 2014 | -36,884 | Sold Out | 36,884 | $0.00 |
| Q3 2014 | +61,384 | New Buy | 61,384 | $11.81 |
| Q4 2014 | +27,800 | Add 45.29% | 89,184 | $13.25 |
| Q1 2015 | +21,900 | Add 24.56% | 111,084 | $17.75 |
| Q2 2015 | +7,300 | Add 6.57% | 118,384 | $17.70 |
| Q3 2015 | -14,700 | Reduce 12.42% | 103,684 | $16.41 |
| Q4 2015 | -15,400 | Reduce 14.85% | 88,284 | $18.44 |
| Q1 2016 | -52,100 | Reduce 59.01% | 36,184 | $18.82 |
| Q2 2016 | -26,500 | Reduce 73.24% | 9,684 | $23.34 |
| Q3 2016 | +41,216 | Add 425.61% | 50,900 | $23.79 |
| Q4 2016 | +40,100 | Add 78.78% | 91,000 | $21.63 |
| Q1 2017 | -91,000 | Sold Out | 91,000 | $0.00 |
| Q4 2017 | +176,079 | New Buy | 176,079 | $24.79 |
| Q1 2018 | -75,229 | Reduce 42.72% | 100,850 | $27.32 |
| Q2 2018 | -100,850 | Sold Out | 100,850 | $0.00 |
| Q1 2019 | +41,325 | New Buy | 41,325 | $38.38 |
| Q2 2019 | -28,819 | Reduce 69.74% | 12,506 | $43.02 |
| Q3 2019 | +14,065 | Add 112.47% | 26,571 | $40.68 |
| Q4 2019 | -26,571 | Sold Out | 26,571 | $0.00 |
| Q1 2020 | +15,808 | New Buy | 15,808 | $32.64 |
| Q2 2020 | -15,808 | Sold Out | 15,808 | $0.00 |
| Q3 2020 | +329,968 | New Buy | 329,968 | $38.21 |
| Q4 2020 | +392,204 | Add 118.86% | 722,172 | $35.95 |
| Q1 2021 | +252,959 | Add 35.03% | 975,131 | $38.65 |
| Q2 2021 | +597,739 | Add 61.30% | 1.57 M | $42.76 |
| Q3 2021 | -33,071 | Reduce 2.10% | 1.54 M | $43.39 |
| Q4 2021 | +287,729 | Add 18.69% | 1.83 M | $42.48 |
| Q1 2022 | +818,484 | Add 44.79% | 2.65 M | $44.29 |
| Q2 2022 | -331,476 | Reduce 12.53% | 2.31 M | $37.27 |
| Q3 2022 | +271,504 | Add 11.73% | 2.59 M | $38.73 |
| Q4 2022 | -640,797 | Reduce 24.78% | 1.95 M | $46.27 |
| Q1 2023 | -3,009 | Reduce 0.15% | 1.94 M | $50.03 |
| Q2 2023 | -203,590 | Reduce 10.48% | 1.74 M | $54.09 |
| Q3 2023 | -3,548 | Reduce 0.20% | 1.74 M | $52.80 |
| Q4 2023 | +22,416 | Add 1.29% | 1.76 M | $57.81 |
| Q1 2024 | -413,013 | Reduce 23.50% | 1.34 M | $68.49 |
| Q2 2024 | -172,553 | Reduce 12.83% | 1.17 M | $77.01 |
| Q3 2024 | -815,182 | Reduce 69.56% | 356,764 | $83.80 |
| Q4 2024 | -193,851 | Reduce 54.34% | 162,913 | $89.32 |
| Q1 2025 | -98,959 | Reduce 60.74% | 63,954 | $100.88 |
| Q2 2025 | -15,670 | Reduce 24.50% | 48,284 | $107.41 |
| Q3 2025 | +111,445 | Add 230.81% | 159,729 | $97.63 |
Ray Dalio's Boston Scientific Corporation Investment FAQs
Ray Dalio first purchased Boston Scientific Corporation (BSX) in Q4 2013, acquiring 123,584 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Boston Scientific Corporation (BSX) for 48 quarters since Q4 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's largest addition to Boston Scientific Corporation (BSX) was in Q1 2022, adding 2,646,012 shares worth $117.19 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 159,729 shares of Boston Scientific Corporation (BSX), valued at approximately $15.59 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Boston Scientific Corporation (BSX) represents approximately 0.06% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's peak holding in Boston Scientific Corporation (BSX) was 2,646,012 shares, as reported at the end of Q1 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.